HENSIFY
Live / Registered — Registered — Section 71 accepted (as of 19 Nov 2024)
What this means for you
Registered since 03 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79219471
- Registration number
- 5435709
- Mark type
- Design + words
- Filed
- 03 Aug 2017
- Published for opposition
- 16 Jan 2018
- Registered
- 03 Apr 2018
- Attorney of record
- Paul Cosmovici
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely, pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy
- Class 010 — Medical apparatus: Diagnostic apparatus for medical use, namely, X-ray apparatus for medical use; radiology screens for medical use
Owner
- Nanobiotix, PARIS, FR
- Nanobiotix, FR
- Nanobiotix, FR
Prosecution history
- 30 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 19 Nov 2024 — REGISTERED-SEC.71 ACCEPTED
- 18 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Apr 2024 — TEAS SECTION 71 RECEIVED
- 04 Aug 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 10 Jul 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Jul 2018 — FINAL DISPOSITION PROCESSED
- 03 Jul 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 03 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2018 — NOTIFICATION PROCESSED BY IB
- 16 Jan 2018 — PUBLISHED FOR OPPOSITION
- 10 Jan 2018 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB